Global Skin Biopsy Market Insights Forecasts to 2033

• The Global Skin Biopsy Market Size was Valued at USD 31.38 Billion in 2023
• The Market Size is Growing at a CAGR of 11.03% from 2023 to 2033
• The Worldwide Skin biopsy market Size is Expected to Reach USD 89.38 Billion by 2033
• Asia Pacific is Expected to Grow the fastest during the forecast period.

The Global Skin Biopsy Market Size is Anticipated to Exceed USD 89.38 Billion by 2033, Growing at a CAGR of 11.03% from 2023 to 2033.

Market Overview

A skin biopsy is a process used to take samples of body's surface cells for laboratory testing. The most common application of a skin biopsy is for skin problem diagnosis. Surgeons, internists, family doctors, and other specialists also do skin biopsies. Because skin problems are becoming more common and people are becoming more aware of the benefits of early diagnosis and treatment, the skin biopsy market is expanding significantly. The main factors propelling this market are the improvements in diagnostic methods, the increasing need for less-invasive treatments, and the increase in healthcare costs. Skin samples are used to diagnose actinic keratosis, dermatitis, psoriasis, and other skin conditions in addition to skin cancer. In a skin biopsy, a sample of skin is taken from the skin lesion or infection, and it is analyzed under a microscope to look for cancerous cells. Through the total elimination of cancerous cells, this procedure not only serves as a diagnostic tool for skin cancer but might so occasionally aid in cancer therapy. Additionally, the procedure is less intrusive, resulting in minor skin injuries that require less healing time. Because skin biopsy offers so many benefits, this procedure is widely used for the detection of skin cancer. Analyzed under a microscope to look for cancerous cells. Through the total elimination of cancerous cells, this procedure not only serves as a diagnostic tool for skin cancer but may also occasionally aid in cancer therapy. Additionally, the procedure is less intrusive, resulting in minor skin injuries that require less healing time. Because skin biopsy offers so many benefits, this procedure is widely used for the detection of skin cancer.

Report Coverage

This research report categorizes the market for the global skin biopsy market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the global skin biopsy market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the global skin biopsy market.

Driving Factors

The availability of improving healthcare infrastructure, an increase in unfulfilled healthcare needs, a rise in the prevalence of skin cancer cases, and a surge in demand for cutting-edge healthcare facilities are all expected to contribute to the growth of the skin biopsy market. Furthermore, the market is expected to have large potential in untapped emerging markets. Further propelling the market's expansion is the rise in the incidence of skin cancer occurrences. Due to a number of variables, such as changes in lifestyle and the environment, there has been a significant increase in cancer diagnoses worldwide within the last ten years. Additionally, the rise in the occurrence of different skin conditions fuels the market's growth during the projection period for skin biopsy procedures. Skin biopsy procedures can be used to identify a variety of skin disorders, including psoriasis, actinic keratosis, dermatitis, skin cancer, and infections. The demand for skin biopsies, as well as skin biopsy products, will thus rise in tandem with the number of occurrences of the mentioned skin disorders. Skin cancer is becoming more common than all other cancers combined in the United States, including breast, prostate, lung, and colon cancer, which is driving up the demand for skin biopsies. During the forecast period, the skin biopsy market is expected to develop due to factors other than skin cancer, such as an increase in the incidence of different skin illnesses.

Restraining Factors

Growth in the market is likely to be significantly hampered by the costs associated with biopsy operations, which range from preoperative evaluations to postoperative care. These operations come at a considerable cost to many people with poor or moderate incomes, and they also come with lower budgets for healthcare systems. Some find it very hard to pay these biopsy procedures, particularly those without adequate insurance coverage. This leads to differences in healthcare due to unequal access to these treatments. Thus, those with low incomes or inadequate insurance may find it difficult to obtain biopsies, which might cause delays or missed diagnosis. Addressing these gaps is critical to ensuring equitable access to healthcare and encouraging market expansion. Fewer skin biopsy operations were performed as a result of social isolation, public health laws, and a decline in the early diagnosis of illnesses. A further factor limiting the market's expansion during the pandemic was the reduction in availability to primary and specialized healthcare as well as a shortage of transportation options. Due to their higher risk of contracting the corona virus, people also declined to seek medical attention for skin cancers.

Market Segmentation

The Global Skin Biopsy Market share is classified into type, indication, and end user.

• The punch biopsy segment is expected to hold the largest share of the global skin biopsy market during the forecast period.   

Based on the type, the global skin biopsy market is divided into shave biopsy, punch biopsy and excisional biopsy. Among these, the punch biopsy segment is expected to hold the largest share of the global skin biopsy market during the forecast period. The increasing popularity of biopsy punches for skin cancer detection and the development of these instruments for more precise diagnosis are responsible for the segment's rise. Important industry participants are also concentrating on developing sophisticated biopsy punches that are inexpensive and simple to use, which will further fuel the market's expansion. Furthermore, a variety of products are offered by prominent players in the skin biopsy industry, which is anticipated to propel market expansion during the projected time.

• The skin cancer segment is expected to hold the largest share of the global skin biopsy market during the forecast period.   

Based on the indication, the global skin biopsy market is divided into skin cancer, actinic keratosis, dermatitis, and others. Among these, the skin cancer segment is expected to hold the largest share of the global skin biopsy market during the forecast period. This is mostly because early identification and diagnosis of skin disorders is essential, and skin cancer is becoming more common place worldwide. Skin biopsy is an important diagnostic technique used for the early detection and treatment of skin cancer, a dangerous condition for which there is no substitute. Because of this, it is anticipated that there will be arise in the market for skin biopsy tools and technologies. Further anticipated factors driving market expansion throughout the projected time are technological developments and the accessibility of an extensive array of skin biopsy goods from major industry participants.

• The hospital segment is expected to hold the largest share of the global skin biopsy market during the forecast period.   

Based on the end user, the global skin biopsy market is divided into, stand-alone practices, multispecialty clinics, hospitals, diagnostic centers, and others. Among these, the hospital segment is expected to hold the largest share of the global skin biopsy market during the forecast period. In the upcoming years, the hospital segment is expected to increase significantly due in large part to the strong demand for healthcare services and treatments in this environment, as well as the large-scale gadget purchases. Further factors predicted to propel segment expansion include the existence of public insurance programs and the accessibility of cutting-edge medical treatments and technology in hospitals. The category is anticipated to develop throughout the projection period because to the higher expenses and complexity of solo practices, as well as the better compensation of dermatologists in group settings and the greater bargaining strength of group practices. A wide range of efficient services and cancer diagnosis are provided by multispecialty clinics, enabling the creation of efficient treatment programs and simple patient management.

Regional Segment Analysis of the global skin biopsy market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the global skin biopsy market over the predicted timeframe.

North America is anticipated to hold the largest share of the global skin biopsy market over the predicted timeframe. Major companies like Integra Lifesciences, Becton, Dickinson and Company, Innovia Medical, and others are driving the market expansion in North America. The expansion of the skin biopsy market is expected to be further fueled by technological advances made by businesses in this sector. Another reason driving the market's expansion is the rise in the prevalence of skin cancer cases in developed nations like the United States, as more people visit hospitals for skin cancer diagnosis and therefore increase demand for skin biopsy equipment.

Asia Pacific is expected to grow at the fastest pace in the global skin biopsy market during the forecast period. The presence of pharmaceutical businesses in the region and the increasing buying power of populous nations like China and India are responsible for the market expansion in this area. Furthermore, it is projected that the population's growing knowledge of skin health issues, their diagnosis, and the available treatments would propel the market during the projected timeframe.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global skin biopsy market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• AccuTec, Inc.
• Cardinal Health Inc.
• Innovia Medical
• Jai Surgicals Ltd.
• Integra LifeSciences,
• Vernacare,
• Dickinson and Company
• KAI Group
• Paramount Surgimed Limited
• Devicor Medical Products,Inc.
• part of Leica Biosystems.
• Gallini Srl
• Hologic, Inc.
• Boston Scientific Corporation
• World Precision Instruments
• Firefly
• SkinIO
• Canfield Scientific, Inc.
• FotoFinder Systems, Inc.
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments

• In May 2023, by releasing the Super Core Advantage Semi-Automatic Biopsy tool, Argon Medical Devices, Inc. expanded its selection of soft tissue biopsy devices in the US market.

• In February 2023, A novel skin sample-based diagnostic test for Alzheimer's disease was released by SynapsDx. Three biomarkers are used in the test to identify Alzheimer's and differentiate it from other types of dementia. It is mostly based on morphometric imaging, which quantifies the development of cells in patient skin samples. Smaller significant masses are seen in the skin cells of Alzheimer's sufferers.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the Global Skin Biopsy Market based on the below-mentioned segments: 

Global Skin Biopsy Market, By Type

• Shave Biopsy
• Excisional Biopsy
• Punch Biopsy
• Others

Global Skin Biopsy Market, By Indication

• Skin cancer
• Actinic keratosis
• Dermatitis
• Others

Global Skin Biopsy Market, By End User

• Hospitals
• Multispecialty Clinics
• Diagnostic Centers
• Others

Global Skin Biopsy Market, Regional

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • Uk
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa